BioCentury
ARTICLE | Clinical News

Androxal enclomiphene regulatory update

February 15, 2010 8:00 AM UTC

Repros submitted a revised indication statement and a literature review to FDA's Division of Reproductive and Urologic Products in response to questions raised by FDA in a Jan. 25 meeting for Androxal...